These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8722550)

  • 21. Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Gallicano K; Sahai J; Swick L; Seguin I; Pakuts A; Cameron DW
    Clin Infect Dis; 1995 Oct; 21(4):1008-11. PubMed ID: 8645788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect calorimetry, body composition and small bowel function in asymptomatic HIV-seropositive women.
    Sharpstone D; Ross H; Hancock M; Phelan M; Crane R; Gazzard B
    Int J STD AIDS; 1997 Nov; 8(11):700-3. PubMed ID: 9363545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in zidovudine serum concentrations.
    Fletcher CV; Balfour HH
    Pharmacotherapy; 1996; 16(6):1154-8. PubMed ID: 8947989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil.
    Lima AA; Silva TM; Gifoni AM; Barrett LJ; McAuliffe IT; Bao Y; Fox JW; Fedorko DP; Guerrant RL
    Am J Gastroenterol; 1997 Oct; 92(10):1861-6. PubMed ID: 9382053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-seropositive thrombocytopenia: the action of zidovudine.
    Boyar A; Beall G
    AIDS; 1991 Nov; 5(11):1351-6. PubMed ID: 1768384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study.
    Dos Reis Serra CH; Mori Koono EE; Kano EK; Schramm SG; Armando YP; Porta V
    Clin Ther; 2008 May; 30(5):902-8. PubMed ID: 18555936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue.
    Freeman RC; Rodriguez GM; French JF
    AIDS Educ Prev; 1996 Feb; 8(1):58-71. PubMed ID: 8703641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of zidovudine. An update.
    Acosta EP; Page LM; Fletcher CV
    Clin Pharmacokinet; 1996 Apr; 30(4):251-62. PubMed ID: 8983858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis.
    Kremer D; Munar MY; Kohlhepp SJ; Swan SK; Stinnett EA; Gilbert DN; Young EW; Bennett WM
    Pharmacotherapy; 1992; 12(1):56-60. PubMed ID: 1549540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
    Stretcher BN
    Clin Pharmacokinet; 1995 Jul; 29(1):46-65. PubMed ID: 7586898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut parasites in HIV-seropositive Zambian adults with diarrhoea.
    Khumalo-Ngwenya B; Luo NP; Chintu C; Sunkutu R; Sakala-Kazembe F; Baboo KS; Mathewson J; Zumla A
    East Afr Med J; 1994 Jun; 71(6):379-83. PubMed ID: 7835260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
    Chompootaweep S; Poonsrisawat J; Xumseang P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.
    Anderson DJ; O'Brien TR; Politch JA; Martinez A; Seage GR; Padian N; Horsburgh CR; Mayer KH
    JAMA; 1992 May; 267(20):2769-74. PubMed ID: 1349654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of zidovudine and acetaminophen in a patient on chronic acetaminophen therapy.
    Burger DM; Meenhorst PL; Koks CH; Beijnen JH
    Ann Pharmacother; 1994 Mar; 28(3):327-30. PubMed ID: 8193419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally administered dextran sulfate is absorbed in HIV-positive individuals.
    Hiebert LM; Wice SM; Jaques LB; Williams KE; Conly JM
    J Lab Clin Med; 1999 Feb; 133(2):161-70. PubMed ID: 9989768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus.
    Miller AR; Griffin GE; Batman P; Farquar C; Forster SM; Pinching AJ; Harris JR
    Q J Med; 1988 Dec; 69(260):1009-19. PubMed ID: 3270081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients.
    Jung D; AbdelHameed MH; Teitelbaum P; Dorr A; Griffy K
    J Clin Pharmacol; 1999 May; 39(5):505-12. PubMed ID: 10234599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of cimetidine and ranitidine administration with zidovudine.
    Fletcher CV; Henry WK; Noormohamed SE; Rhame FS; Balfour HH
    Pharmacotherapy; 1995; 15(6):701-8. PubMed ID: 8602376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics of zidovudine (AZT) and its metabolite (G-AZT) in healthy subjects and in patients with kidney failure].
    Pioger JC; Taburet AM; Colin JN; Colaneri S; Fillastre JP; Singlas E
    Therapie; 1989; 44(6):401-4. PubMed ID: 2623653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.